Breathe away the pain: new study tests Drug-Free injection relief

NCT ID NCT07172984

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether controlled breathing exercises can control pain during joint injections as well as local anesthesia. 136 participants will be randomly assigned to either receive lidocaine (standard care) or practice 5-minute breathing cycles. The goal is to see if the breathing group feels no more pain than the anesthesia group, potentially offering a needle-free, drug-free alternative.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
breathing exercises (cardiac coherence technique)
What this could lead to
If it works, this could offer a drug-free way to manage pain during joint injections, reducing reliance on local anesthetics.
What could go wrong
This is a small, early-stage trial (136 people). Breathing may not work as well as anesthesia for everyone, and results may not apply to other procedures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 136 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient scheduled to undergo therapeutic ultrasound-guided joint or periarticular injection. * Patient able to sign an informed consent form to participate in the study Exclusion Criteria: * Patient able to sign an informed consent form to participate in the study - - Allergy to the injection product or anesthetic. * Injection not allowing the use of a local anesthetic due to insufficient joint volume (e.g., fingers/toes). * Epidural injection via the sacrococcygeal hiatus. * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain management are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre Hospitalier Métropole Savoie

    RECRUITING

    Chambéry, 73000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.